Gonorrhea--recommended treatment schecules, 1974.
Gonorrhea, the nation's second most frequently reported communicable disease, will affect more than a million persons this year. The following is the latest treatment schedule issued by the USPHS Center for Disease Control, Atlanta.
D000293:Adolescent; D000667:Ampicillin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D008297:Male; D010402:Penicillin G Procaine / Q000627:therapeutic use; D010612:Pharyngitis / Q000188:drug therapy; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D011339:Probenecid / Q000627:therapeutic use; D012488:Salpingitis / Q000188:drug therapy; D000198:Spectinomycin / Q000627:therapeutic use; D013440:Sulfides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D013830:Thiadiazoles / Q000627:therapeutic use; D014526:Urethritis / Q000188:drug therapy
D002511:Cephalosporins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles; D010402:Penicillin G Procaine; D004917:Erythromycin; D000667:Ampicillin; D000198:Spectinomycin; D013752:Tetracycline; D011339:Probenecid